No Data
No Data
No Data
No Data
No Data
NeuroPace(NPCE.US) 10% Shareholder Sells US$913.06K in Common Stock
$NeuroPace(NPCE.US)$ 10% Shareholder ORBIMED ADVISORS LLC sold 64,653 shares of common stock on Apr 19, 22, 23, 2024 at an average price of $14.12 for a total value of $913.06K. This transaction invol
Futu NewsApr 24 07:19
NeuroPace(NPCE.US) 10% Shareholder Sells US$238.23K in Common Stock
$NeuroPace(NPCE.US)$ 10% Shareholder ORBIMED ADVISORS LLC sold 16,992 shares of common stock on Apr 16, 17, 18, 2024 at an average price of $14.02 for a total value of $238.23K. This transaction invol
Futu NewsApr 19 05:50
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report
GlobeNewswireApr 18 04:05
NeuroPace(NPCE.US) 10% Shareholder Sells US$7.03 Million in Common Stock
$NeuroPace(NPCE.US)$ 10% Shareholder ORBIMED ADVISORS LLC sold 485K shares of common stock on Apr 11, 12, 2024 at an average price of $14.49 for a total value of $7.03 million. This transaction involv
Futu NewsApr 16 06:08
Is NeuroPace (NASDAQ:NPCE) Using Debt In A Risky Way?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how
Simply Wall StApr 12 18:18
'Time to Hit Buy,' Says Wells Fargo About These 2 Stocks
Yahoo FinanceApr 5 00:20
No Data
No Data